APRIL promotes cell-cycle progression in primary multiple myeloma cells: influence of D-type cyclin group and translocation status.

作者: John Quinn , Janet Glassford , Laura Percy , Philippa Munson , Teresa Marafioti

DOI: 10.1182/BLOOD-2010-01-264424

关键词:

摘要: A proliferation-inducing ligand (APRIL) promotes survival and drug resistance in multiple myeloma (MM) cell lines. We studied the effect of APRIL on cell-cycle behavior primary MM cells correlated our findings with D-type cyclin expression by immunohistochemistry and/or Western blotting. In cases, expressing D2 significantly increased percentage CD138(+) S + G(2)/M phase (from 8.4% ± 1.9% to 14.3% 2.6%, n = 15, P < .01), whereas a lesser was seen cases D1 (n 18). Cell-cycle response most marked for D2-expressing IgH translocations (P .01) accompanied D2, CDK4, CDK6, phospho-retinoblastoma protein. proteins D1(+) were not modulated APRIL. Surface B-cell maturation antigen transmembrane activator calcium-modulating cyclophilin interactor different between D2(+) cells. observed activation nuclear factor-κB PI3-kinase pathways both conclusion, stimulates G(1)/S progression bearing but has minimal cells, suggesting from D/translocation classes rely mechanisms re-entry.

参考文章(43)
Michele Pagano, Anne M. Theodoras, Jerry W. Shay, Sun W. Tam, Giulio F. Draetta, Differential expression and regulation of Cyclin D1 protein in normal and tumor human cells: association with Cdk4 is required for Cyclin D1 function in G1 progression. Oncogene. ,vol. 9, pp. 2663- 2674 ,(1994)
Micah J. Benson, Stacey R. Dillon, Emanuela Castigli, Raif S. Geha, Shengli Xu, Kong-Peng Lam, Randolph J. Noelle, Cutting edge: the dependence of plasma cells and independence of memory B cells on BAFF and APRIL. Journal of Immunology. ,vol. 180, pp. 3655- 3659 ,(2008) , 10.4049/JIMMUNOL.180.6.3655
Julia Kirshner, Kyle J. Thulien, Lorri D. Martin, Carina Debes Marun, Tony Reiman, Andrew R. Belch, Linda M. Pilarski, A unique three-dimensional model for evaluating the impact of therapy on multiple myeloma. Blood. ,vol. 112, pp. 2935- 2945 ,(2008) , 10.1182/BLOOD-2008-02-142430
Janet Glassford, Neil Rabin, Eric W.-F. Lam, Kwee L. Yong, Functional regulation of D-type cyclins by insulin-like growth factor-I and serum in multiple myeloma cells. British Journal of Haematology. ,vol. 139, pp. 243- 254 ,(2007) , 10.1111/J.1365-2141.2007.06789.X
Christina M. Annunziata, R. Eric Davis, Yulia Demchenko, William Bellamy, Ana Gabrea, Fenghuang Zhan, Georg Lenz, Ichiro Hanamura, George Wright, Wenming Xiao, Sandeep Dave, Elaine M. Hurt, Bruce Tan, Hong Zhao, Owen Stephens, Madhumita Santra, David R. Williams, Lenny Dang, Bart Barlogie, John D. Shaughnessy, W. Michael Kuehl, Louis M. Staudt, Frequent Engagement of the Classical and Alternative NF-κB Pathways by Diverse Genetic Abnormalities in Multiple Myeloma Cancer Cell. ,vol. 12, pp. 115- 130 ,(2007) , 10.1016/J.CCR.2007.07.004
Fabienne Mackay, Pascal Schneider, Cracking the BAFF code Nature Reviews Immunology. ,vol. 9, pp. 491- 502 ,(2009) , 10.1038/NRI2572
Johannes Drach, Claus Gattringer, Herta Glassl, Doris Drach, Heinz Huber, The biological and clinical significance of the KI-67 growth fraction in multiple myeloma Hematological Oncology. ,vol. 10, pp. 125- 134 ,(1992) , 10.1002/HON.2900100209
Mamta Gupta, Stacey R. Dillon, Steven C. Ziesmer, Andrew L. Feldman, Thomas E. Witzig, Stephen M. Ansell, James R. Cerhan, Anne J. Novak, A proliferation-inducing ligand mediates follicular lymphoma B-cell proliferation and cyclin D1 expression through phosphatidylinositol 3-kinase-regulated mammalian target of rapamycin activation. Blood. ,vol. 113, pp. 5206- 5216 ,(2009) , 10.1182/BLOOD-2008-09-179762
J. Moreaux, D. Hose, M. Jourdan, T. Reme, M. Hundemer, M. Moos, N. Robert, P. Moine, J. De Vos, H. Goldschmidt, B. Klein, TACI expression is associated with a mature bone marrow plasma cell signature and C-MAF overexpression in human myeloma cell lines. Haematologica. ,vol. 92, pp. 803- 811 ,(2007) , 10.3324/HAEMATOL.10574
P. Leif Bergsagel, W. Michael Kuehl, Molecular Pathogenesis and a Consequent Classification of Multiple Myeloma Journal of Clinical Oncology. ,vol. 23, pp. 6333- 6338 ,(2005) , 10.1200/JCO.2005.05.021